Cited by 106Connective tissue disorders researchDermatological and Skeletal DisordersSkin and Cellular Biology Research

The DOI matches its Crossref record; the references it cites are not checked yet.

Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation

Open access

Abstract

BACKGROUND: The kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) (OMIM 225400) is a rare inheritable connective tissue disorder characterized by a deficiency of collagen lysyl hydroxylase 1 (LH1; EC 1.14.11.4) due to mutations in PLOD1. Biochemically this results in underhydroxylation of collagen lysyl residues and, hence, an abnormal pattern of lysyl pyridinoline (LP) and hydroxylysyl pyridinoline (HP) crosslinks excreted in the urine. Clinically the disorder is characterized by hypotonia and kyphoscoliosis at birth, joint hypermobility, and skin hyperelasticity and fragility. Severe hypotonia usually leads to delay in gross motor development, whereas cognitive development is reported to be normal. METHODS: We describe the clinical, biochemical and molecular characterisation, as well as electron microscopy findings of skin, in 15 patients newly diagnosed with this rare type of Ehlers-Danlos syndrome. RESULTS: Age at diagnosis ranged from 5 months to 27 years, with only 1/3 of the patients been diagnosed correctly in the first year of life. A similar disease frequency was found in females and males, however a broad disease severity spectrum (intra- and interfamilial), independent of molecular background or biochemical phenotype, was observed. Kyphoscoliosis, one of the main clinical features was not present at birth in 4 patients. Importantly we also noted the occurrence of vascular rupture antenatally and postnatally, as well as developmental delay in 5 patients. CONCLUSION: In view of these findings we propose that EDS VIA is a highly variable clinical entity, presenting with a broad clinical spectrum, which may also be associated with cognitive delay and an increased risk for vascular events. Genotype/phenotype association studies and additional molecular investigations in more extended EDS VIA populations will be necessary to further elucidate the cause of the variability of the disease severity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1750-1172-6-46

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intelligence is usually normal in kEDS-PLOD1, but learning disabilities have been reported in eight patients (two of whom had antenatal or perinatal intracranial bleeds).

    “Intelligence is usually normal but learning disabilities have been reported in eight patients (two of these patients were reported to have antenatal or perinatal intracranial bleeds) [Wenstrup et al., 1989;Rohrbach et al., 2011].”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Rohrbach et al., 2011

    The Discussion (page unavailable) says intellect was historically considered unaffected and reports delayed cognitive function in 5 of 12 index patients. The Results (Clinical features; page unavailable) document an antenatal/neonatal brain haemorrhage in one patient. This paper does not establish the cited totals of eight patients with learning disabilities or two with intracranial bleeds. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • A range of clinical severity is observed in individuals with kEDS-PLOD1 for each of the systems discussed.

    “A range of clinical severity is observed in individuals with kEDS-PLOD1 for each of the systems discussed as detailed in the above section [Steinmann et al., 2002;Rohrbach et al., 2011].”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Rohrbach et al., 2011

  • LH1 deficiency results in underhydroxylation of lysyl residues and underglycosylation of hydroxylysyl residues in collagens, and hence impaired cross-link formation with consequent mechanical instability of the affected tissues.

    “LH1 deficiency results in underhydroxylation of lysyl residues and underglycosylation of hydroxylysyl residues in collagens and, hence, impaired cross-link formation with consequent mechanical instability of the affected tissues [Rohrbach et al., 2011].”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Rohrbach et al., 2011

  • kEDS-PLOD1 is caused by deficiency of the collagen-modifying enzyme procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1 or LH1) due to homozygosity or compound heterozygosity for mutated PLOD1 alleles.

    “kEDS-PLOD1 is caused by deficiency of the collagen-modifying enzyme procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1 or LH1 [lysylhydroxylase1]) due to homozygosity or compound heterozygosity for mutated PLOD1 alleles.”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Rohrbach et al., 2011

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 24 · Cited by 106

Research works printed but not linked: 16

  1. 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O · DOI · Paper page
  2. 10.1002/ajmg.a.20326 · DOI
  3. 10.1038/ng1192-228 · DOI
  4. 10.1002/(SICI)1096-8628(19980806)78:5<455::AID-AJMG11>3.0.CO;2-E · DOI
  5. 10.1373/clinchem.2008.105262 · DOI
  6. 10.1002/ajmg.a.30529 · DOI
  7. 10.3109/03008208509152396 · DOI
  8. 10.1016/j.ymgme.2005.04.014 · DOI
  9. 10.1016/S0945-053X(99)00055-4 · DOI
  10. 10.1016/j.matbio.2004.11.002 · DOI
  11. 10.1007/s00439-010-0829-0 · DOI
  12. 10.1016/0022-2836(91)90380-O · DOI
  13. 10.1093/nar/gkg616 · DOI
  14. 10.1093/hmg/ddl171 · DOI
  15. 10.1016/j.nmd.2007.11.006 · DOI
  16. 10.1002/(SICI)1096-8628(19971003)72:1<94::AID-AJMG20>3.0.CO;2-O · DOI

Metadata

Authors
Rohrbach, M., Vandersteen, A., Yiş, U., Serdaroglu, G., Ataman, E., Chopra, M., Garcia, S., Jones, K., Kariminejad, A., Kraenzlin, M., Marcelis, C., Baumgartner, M., & Giunta, C.
Affiliations
  • University Children's Hospital Zurich (CH)
  • London North West Healthcare NHS Trust (GB)
  • Gaziantep Children's Hospital (TR)
  • Ege University (TR)
  • The University of Sydney (AU)
  • University Hospital of Basel (CH)
  • Radboud University Medical Center (NL)
Corresponding author
Rohrbach, Marianne
Venue
Orphanet Journal of Rare Diseases
Published
2011
Volume
6
Issue
1
Pages
46
ISSN
1750-1172 (ISSN-L)
OpenAlex
W2119847760
Cited by
106
References
24
Citations by year
2026: 4 · 2025: 7 · 2024: 11 · 2023: 5 · 2022: 10 · 2021: 10 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 7 · 2016: 6 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 5
FWCI
2.59
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Orphanet Journal of Rare Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Ege Üniversitesi
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
Keywords
PLOD1, connective tissue diseases, phenotypic variability, disease severity spectrum, kyphoscoliosis, hypotonia, developmental delay, vascular rupture, genotype-phenotype correlation, skin ultrastructure
MeSH terms
Adolescent, Adult, Amino Acids, Biopsy, Cells, Cultured, Child, Developmental Disabilities, Child, Preschool, DNA Mutational Analysis, Ehlers-Danlos Syndrome, Female, Fibroblasts, Genotype, Humans, Infant, Kyphosis, Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase, Male, Muscle Hypotonia, Phenotype, Scoliosis, Skin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review